References
- World Health Organization. Coronavirus disease (COVID-19) pandemic; 2020 [accessed 2020 May 28]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
- Thanh Le T, Andreadakis Z, Kumar A, Román RG, Tollefsen S, Saville M, Mayhew S. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19:305‐06.
- Ella KM, Mohan VK. Coronavirus vaccines: light at the end of the tunnel. Indian Pediatr. 2020;57(5):407‐10. doi:10.1007/s13312-020-1812-z.
- Mahase E. Covid-19: what do we know so far about a vaccine? BMJ. 2020;369:m1679. doi:10.1136/bmj.m1679.
- Reducing health care workers absenteeism in Covid-19 pandemic through BCG vaccine (BCG-CORONA); 2020 [accessed 2020 Apr 14]. https://clinicaltrials.gov/ct2/show/NCT04328441.
- BCG vaccination to protect healthcare workers against COVID-19 (BRACE); 2020 [accessed 2020 Apr 14]. https://clinicaltrials.gov/ct2/show/NCT04327206.
- Austell J. Can an oral polio vaccine help stop COVID-19? [blog]. Global Virus Network (GVN); 2020 [accessed 2020 Apr 14]. https://gvn.org/dr-robert-gallo-exclusive-broadcast-interview-with-walter-isaacson-of-amanpour-co/.
- Shanker V. Measles immunization: worth considering containment strategy for SARS-CoV-2 global outbreak. Indian Pediatr. 2020;57(4):380. doi:10.1007/s13312-020-1804-z.
- PGI to test leprosy vaccine on Covid-19 patients.2020. Hindustan Times. 2020 Apr 22 [accessed 2020 Apr 27]. https://www.hindustantimes.com/chandigarh/pgi-to-test-leprosy-vaccine-on-covid-19-patients/story-0DHH4GS8mANbUZNRZj2kYK.html.
- Wu Y, Jing W, Liu J, Ma Q, Yuan J, Wang Y, Du M, Min Liu M. Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries. Sci Total Environ. 2020;729:139051. doi:10.1016/j.scitotenv.2020.139051.
- World Health Organization. SAGE working group on BCG vaccines and WHO secretariat. Report on BCG vaccine use for protection against mycobacterial infections including tuberculosis, leprosy, and other nontuberculous mycobacteria (NTM) infections; 2017 [accessed 2020 Apr 18]. https://www.who.int/immunization/sage/meetings/2017/october/1_BCG_report_revised_version_online.pdf.
- Uthayakumar D, Paris S, Chapat L, Freyburger L, Poulet H, De Luca K. Non-specific effects of vaccines illustrated through the BCG example: from observations to demonstrations. Front Immunol. 2018;9:2869. doi:10.3389/fimmu.2018.02869.
- Aaby P, Roth A, Ravn H, Napirna BM, Rodrigues A, Lisse IM, Stensballe L, Diness BR, Lausch KR, Lund N, et al. Randomized trial of BCG vaccination at birth to low-birthweight children: beneficial nonspecific effects in the neonatal period? J Infect Dis. 2011;204(2):245–52. doi:10.1093/infdis/jir240.
- Biering-Sørensen S, Aaby P, Napirna BM, Roth A, Ravn H, Rodrigues A, Whittle H, Benn CS. Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guérin vaccination at first health center contact. Pediatr Infect Dis J. 2012;31(3):306–08. doi:10.1097/INF.0b013e3182458289.
- Aaby P, Kollmann TR, Benn CS. Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges. Nat Immunol. 2014;15(10):895–99. doi:10.1038/ni.2961.
- de Castro MJ, Pardo-Seco J, Martinón-Torres F. Nonspecific (Heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis. Clin Infect Dis. 2015;60(11):1611–19. doi:10.1093/cid/civ144.
- Jensen KJ, Larsen N, Biering-Sørensen S, Andersen A, Eriksen HB, Monteiro I, Hougaard D, Aaby P, Netea MG, Flanagan KL, et al. Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial. J Infect Dis. 2015;211(6):956–67. doi:10.1093/infdis/jiu508.
- Higgins JP, Soares-Weiser K, López-López JA, Kakourou A, Chaplin K, Christensen H, Martin NK, Sterne JAC, Reingold AL. Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review. BMJ. 2016;355:i5170. doi:10.1136/bmj.i5170.
- Pollard AJ, Finn A, Curtis N. Non-specific effects of vaccines: plausible and potentially important, but implications uncertain. Arch Dis Child. 2017;102(11):1077–81. doi:10.1136/archdischild-2015-310282.
- Arts RJW, Moorlag SJCFM, Novakovic B, Li Y, Wang SY, Oosting M, Kumar V, Xavier RJ, Wijmenga C, Joosten LAB, et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe. 2018;23(1):89–100. doi:10.1016/j.chom.2017.12.010.
- Moorlag SJCFM, Arts RJW, van Crevel R, Netea MG. Non-specific effects of BCG vaccine on viral infections. Clin Microbiol Infect. 2019;25(12):1473–78. doi:10.1016/j.cmi.2019.04.020.
- Zimmermann P, Curtis N. The influence of BCG on vaccine responses - a systematic review. Expert Rev Vaccines. 2018;17(6):547–54. doi:10.1080/14760584.2018.1483727.
- Fuge O, Vasdev N, Allchorne P, Green JS. Immunotherapy for bladder cancer. Res Rep Urol. 2015;7:65–79. doi:10.2147/RRU.S63447.
- Kühtreiber WM, Tran L, Kim T, Dybala M, Nguyen B, Plager S, Huang D, Janes S, Defusco A, Baum D, et al. Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations. NPJ Vaccines. 2018;3(1):23. doi:10.1038/s41541-018-0062-8.
- Usher NT, Chang S, Howard RS, Martinez A, Harrison LH, Santosham M, Aronson NE. Association of BCG vaccination in childhood with subsequent cancer diagnoses: A 60-year follow-up of a clinical trial. JAMA Netw Open. 2019;2(9):e1912014. doi:10.1001/jamanetworkopen.2019.12014.
- Saeed S, Quintin J, Kerstens HHD, Rao NA, Aghajanirefah A, Matarese F, Cheng SC, Ratter J, Berentsen K, van der Ent MA, et al. Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity. Science. 2014;345(6204):1251086. doi:10.1126/science.1251086.
- Mehta S, Jeffrey KL. Beyond receptors and signaling: epigenetic factors in the regulation of innate immunity. Immunol Cell Biol. 2015;93(3):233–44. doi:10.1038/icb.2014.101.
- Italiani P, Boraschi D. Induction of innate immune memory by engineered nanoparticles: a hypothesis that may become true. Front Immunol. 2017;8:734. doi:10.3389/fimmu.2017.00734.
- Brosch R, Gordon SV, Garnier T, Eiglmeier K, Frigui W, Valenti P. Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci U S A. 2007;104(13):5596–601. doi:10.1073/pnas.0700869104.
- Shann F. Editorial commentary: different strains of bacillus calmette–guérin vaccine have very different effects on tuberculosis and on unrelated infections. Clin Infect Dis. 2015;61(6):960–62. doi:10.1093/cid/civ454.
- Moliva JI, Turner J, Torrelles JB. Immune responses to Bacillus Calmette-Guérin vaccination: why do they fail to protect against mycobacterium tuberculosis? Front Immunol. 2017;8:407. doi:10.3389/fimmu.2017.00407.
- World Health Organization. Bacille Calmette-Guérin (BCG) vaccination and COVID-19. Scientific Brief, 12 April 2020; 2020 [accessed 2020 April 14]. https://www.who.int/news-room/commentaries/detail/bacille-calmette-gu%C3%A9rin-(bcg)-vaccination-and-covid-19.